Connection

MILTON FINEGOLD to Cell Line, Tumor

This is a "connection" page, showing publications MILTON FINEGOLD has written about Cell Line, Tumor.
Connection Strength

0.088
  1. Hep G2 is a hepatoblastoma-derived cell line. Hum Pathol. 2009 Oct; 40(10):1512-5.
    View in: PubMed
    Score: 0.030
  2. Growth Factor-Independent 1 Is a Tumor Suppressor Gene in Colorectal Cancer. Mol Cancer Res. 2019 03; 17(3):697-708.
    View in: PubMed
    Score: 0.014
  3. Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer. J Hepatol. 2016 08; 65(2):325-33.
    View in: PubMed
    Score: 0.012
  4. P2X3 purinergic receptor overexpression is associated with poor recurrence-free survival in hepatocellular carcinoma patients. Oncotarget. 2015 Dec 01; 6(38):41162-79.
    View in: PubMed
    Score: 0.012
  5. ?-catenin activation in a novel liver progenitor cell type is sufficient to cause hepatocellular carcinoma and hepatoblastoma. Cancer Res. 2014 Aug 15; 74(16):4515-25.
    View in: PubMed
    Score: 0.010
  6. Farnesoid X receptor inhibits gankyrin in mouse livers and prevents development of liver cancer. Hepatology. 2013 Mar; 57(3):1098-106.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.